From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

TrakM8! Timber! Chickens come home to roost big time!

By Tom Winnifrith, The Sheriff of AIM | Friday 16 November 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


For a while it was going so well for TrakM8 (TRAK). Put out RNS’s saying you had cash when you had debt, record ramptastic interviews with thirsty Paul Scott and get him ramping hard, make really dodgy acquisitions that made no sense, generate no cash and watch the shares go ever higher. Then the Sheriff of AIM started to look underneath the hood and kick the tyres. The shares were 360p back then. They are opening today at just 23p to sell after a truly diabolical set of results and a (lack of) profits warning. If you were at the heart of the rampfest, it would be enough to turn a man to drink.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 10:59:25